Skip to content

LivaNova PLC (LIVN) stock: revenue, earnings & dividend

LivaNova PLC (LIVN, Nasdaq): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener LIVN · Nasdaq Medizintechnik & Messgeräte GB-

Key figures

Fiscal year
2025
Revenue
1.39 bn $
Revenue growth
10.7 %
Revenue growth 5y (p.a.)
8.2 %
Net income
-242.5 m $
Net margin
-17.5 %
Operating margin
14.4 %
Earnings per share (diluted)
-4.45 $
Dividend per share
–
Payout ratio
–
Consecutive dividend years
–
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
–
Total assets
2.61 bn $
Equity
1.2 bn $
Equity ratio
46.1 %
Return on equity
-20.2 %
Cash
636 m $
Operating cash flow
254 m $
Free cash flow
173 m $
Shares outstanding
55,086,809

History

Revenue by fiscal year

2016 965 m $
2017 1.01 bn $
2018 1.11 bn $
2019 1.08 bn $
2020 934 m $
2021 1.04 bn $
2022 1.02 bn $
2023 1.15 bn $
2024 1.25 bn $
2025 1.39 bn $

Net income by fiscal year

2016 -62.79 m $
2017 -25.09 m $
2018 -189.4 m $
2019 -157.64 m $
2020 -348.82 m $
2021 -135.8 m $
2022 -86.2 m $
2023 17.6 m $
2024 63.2 m $
2025 -242.5 m $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20251.39 bn $-242.5 m $-4.45 $–254 m $
20241.25 bn $63.2 m $1.16 $–183 m $
20231.15 bn $17.6 m $0.32 $–74.9 m $
20221.02 bn $-86.2 m $-1.61 $–69.9 m $
20211.04 bn $-135.8 m $-2.68 $–103 m $
2020934 m $-348.82 m $-7.18 $–-79.42 m $
20191.08 bn $-157.64 m $-3.26 $–-91.14 m $
20181.11 bn $-189.4 m $-3.91 $–120 m $
20171.01 bn $-25.09 m $-0.52 $–91.3 m $
2016965 m $-62.79 m $-1.28 $–90.2 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)